Search research articles
Contact Us
Filters
Showing results (11-20 of 17) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 17 results.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 21, 2022
Management of toxicities from immunotherapy: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up
J Haanen, M Obeid, L Spain, et al.
ESMO Open
|
June 3, 2025
Cardiovascular toxicity of breast cancer treatments: from understanding to enhancing survivorship care
C Dauccia, E Agostinetto, L Arecco, et al.
Cell Death & Disease
|
May 8, 2015
Myocardial MiR-30 downregulation triggered by doxorubicin drives alterations in β-adrenergic signaling and enhances apoptosis
L Roca-Alonso, L Castellano, A Mills, et al.
British Journal of Pharmacology
|
October 11, 2014
Physiological, pharmacological and toxicological considerations of drug-induced structural cardiac injury
M J Cross, B R Berridge, P J M Clements, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 22, 2020
Management of cardiac disease in cancer patients throughout oncological treatment: ESMO consensus recommendations
G Curigliano, D Lenihan, M Fradley, et al.
European Heart Journal. Quality of Care & Clinical Outcomes
|
October 31, 2022
European Society of Cardiology quality indicators for the prevention and management of cancer therapy-related cardiovascular toxicity in cancer treatment
G A Lee, S Aktaa, E Baker, et al.
Gene Therapy
|
July 17, 2020
Investigation of the safety and feasibility of AAV1/SERCA2a gene transfer in patients with chronic heart failure supported with a left ventricular assist device - the SERCA-LVAD TRIAL
A R Lyon, D Babalis, A C Morley-Smith, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 17) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 17 results.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 21, 2022
Management of toxicities from immunotherapy: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up
J Haanen, M Obeid, L Spain, et al.
ESMO Open
|
June 3, 2025
Cardiovascular toxicity of breast cancer treatments: from understanding to enhancing survivorship care
C Dauccia, E Agostinetto, L Arecco, et al.
Cell Death & Disease
|
May 8, 2015
Myocardial MiR-30 downregulation triggered by doxorubicin drives alterations in β-adrenergic signaling and enhances apoptosis
L Roca-Alonso, L Castellano, A Mills, et al.
British Journal of Pharmacology
|
October 11, 2014
Physiological, pharmacological and toxicological considerations of drug-induced structural cardiac injury
M J Cross, B R Berridge, P J M Clements, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 22, 2020
Management of cardiac disease in cancer patients throughout oncological treatment: ESMO consensus recommendations
G Curigliano, D Lenihan, M Fradley, et al.
European Heart Journal. Quality of Care & Clinical Outcomes
|
October 31, 2022
European Society of Cardiology quality indicators for the prevention and management of cancer therapy-related cardiovascular toxicity in cancer treatment
G A Lee, S Aktaa, E Baker, et al.
Gene Therapy
|
July 17, 2020
Investigation of the safety and feasibility of AAV1/SERCA2a gene transfer in patients with chronic heart failure supported with a left ventricular assist device - the SERCA-LVAD TRIAL
A R Lyon, D Babalis, A C Morley-Smith, et al.
Page
of 2